Arés Luque A, Ballesteros Pomar M D, Hernández Echebarría L
Servicio de Neurología, Hospital de León, España.
Neurologia. 2002 Dec;17(10):628-32.
Hashimoto's autoimmune thyroiditis is a common cause of thyroid disease. Neurological dysfunction related to thyroid hypo or hyperfunction is well known. Not so is autoimmune thyroid disease-associated or Hashimoto's encephalopathy, which includes different neurological manifestations appearing in the context of autoimmune thyroiditis with normal hormone levels. Around fifty cases have been reported since the first description by Brain in 1966. Pathogenesis is unknown, although the most accepted theory points out to an autoimmune cerebral dysfunction. There are two different clinical presentations. The vasculitic type is characterized by relapsing-remitting stroke-like episodes. The diffuse-progressive type shows insidious cognitive impairment, confusion, psychosis, somnolence and coma. Cerebrospinal fluid is abnormal in more than 80% of patients, with high protein levels and mononuclear pleocytosis. Steroids are the treatment of choice, although favourable evolution have been reported spontaneously or after thyroxine treatment.
桥本氏自身免疫性甲状腺炎是甲状腺疾病的常见病因。甲状腺功能减退或亢进相关的神经功能障碍已为人熟知。而自身免疫性甲状腺疾病相关的或桥本氏脑病却并非如此,它包括在自身免疫性甲状腺炎且激素水平正常的情况下出现的不同神经表现。自1966年Brain首次描述以来,已报告了约50例病例。尽管最被认可的理论指出是自身免疫性脑功能障碍,但其发病机制尚不清楚。有两种不同的临床表现。血管炎型的特征是复发-缓解型类似中风的发作。弥漫性进行型表现为隐匿性认知障碍、意识模糊、精神病、嗜睡和昏迷。超过80%的患者脑脊液异常,蛋白质水平高且有单核细胞增多。类固醇是首选治疗方法,不过也有报告称自发或在甲状腺素治疗后病情有良好转归。